Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell–Mediated Cytotoxicity
The Journal of Immunology · 2024
DOI: 10.4049/jimmunol.2300334 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, 2024. Verfasst von Zachary L Z Hay und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO. Hauptthemen laut MEDLINE: Leukemia, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIAID NIH HHS, HHS | National Institutes of Health.
Abstract (Originalsprache)
Granzymes are a family of proteases used by CD8 T cells to mediate cytotoxicity and other less-defined activities. The substrate and mechanism of action of many granzymes are unknown, although they diverge among the family members. In this study, we show that mouse CD8+ tumor-infiltrating lymphocytes (TILs) express a unique array of granzymes relative to CD8 T cells outside the tumor microenvironment in multiple tumor models. Granzyme F was one of the most highly upregulated genes in TILs and was exclusively detected in PD1/TIM3 double-positive CD8 TILs. To determine the function of granzyme F and to improve the cytotoxic response to leukemia, we constructed chimeric Ag receptor T cells to overexpress a single granzyme, granzyme F or the better-characterized granzyme A or B. Using these doubly recombinant T cells, we demonstrated that granzyme F expression improved T cell–mediated cytotoxicity against target leukemia cells and induced a form of cell death other than chimeric Ag receptor T cells expressing only endogenous granzymes or exogenous granzyme A or B. However, increasing expression of granzyme F also had a detrimental impact on the viability of the host T cells, decreasing their persistence in circulation in vivo. These results suggest a unique role for granzyme F as a marker of terminally differentiated CD8 T cells with increased cytotoxicity, but also increased self-directed cytotoxicity, suggesting a potential mechanism for the end of the terminal exhaustion pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbiology, University of Colorado School of Medicine, Aurora, CO.
- Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO.
- Center for Genes, Environment and Health, National Jewish Health, Denver, CO.
- Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, CO.
- Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, CO.
- Department of Veterans Affairs Medical Center, Veterans Affairs Eastern Colorado Health Care System, Aurora, CO.
ORCID-Profile: Zachary L Z Hay, Dale D Kim, Jennifer M Cimons, Jennifer R Knapp, M Eric Kohler, Tiffany M Zúñiga, Faye A Camp, Mayumi Fujita, Xiao-Jing Wang, Brian P O'Connor, Jill E Slansky
Förderung
- NCI NIH HHS
- NIAID NIH HHS
- HHS | National Institutes of Health
Zitieren
APA
Hay, Z. L. Z., Kim, D. D., Cimons, J. M., Knapp, J. R., Kohler, M. E., Quansah, M., Zúñiga, T. M., Camp, F. A., Fujita, M., Wang, X. J., O'Connor, B. P., & Slansky, J. E. (2024). Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell–Mediated Cytotoxicity. The Journal of Immunology. https://doi.org/10.4049/jimmunol.2300334
Vancouver
Hay ZLZ, Kim DD, Cimons JM, Knapp JR, Kohler ME, Quansah M, et al. Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell–Mediated Cytotoxicity. The Journal of Immunology. 2024. doi:10.4049/jimmunol.2300334
BibTeX
@article{Hay2024,
author = {Hay, Zachary L Z and Kim, Dale D and Cimons, Jennifer M and Knapp, Jennifer R and Kohler, M Eric and Quansah, Mary and Zúñiga, Tiffany M and Camp, Faye A and Fujita, Mayumi and Wang, Xiao-Jing and O'Connor, Brian P and Slansky, Jill E},
title = {Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell–Mediated Cytotoxicity},
journal = {The Journal of Immunology},
year = {2024},
doi = {10.4049/jimmunol.2300334}
}
EUVIMED